Nonalcoholic Fatty Liver Disease and Its Complex Relation with Type 2 Diabetes Mellitus—From Prevalence to Diagnostic Approach and Treatment Strategies

por Diaconu, Cosmina-Theodora, Guja, Cristian
Publicado 2022

Structural Properties of Gene Promoters Highlight More than Two Phenotypes of Diabetes

por Ionescu-Tîrgovişte, Constantin, Gagniuc, Paul Aurelian, Guja, Cristian
Publicado 2015

Cancer Specific Mortality in Insulin-Treated Type 2 Diabetes Patients

por Ioacara, Sorin, Guja, Cristian, Ionescu-Tirgoviste, Constantin, Fica, Simona, Roden, Michael
Publicado 2014

Real-world evidence on the use of a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) in people with suboptimally controlled type 2 diabetes in Romania: a pr...

por Bala, Cornelia, Cerghizan, Anca, Mihai, Bogdan-Mircea, Moise, Mihaela, Guja, Cristian
Publicado 2022

Cardiovascular Mortality in Type 2 Diabetes Patients with Incident Exposure to Insulin Glargine

por Ioacara, Sorin, Guja, Cristian, Reghina, Aura, Martin, Sorina, Sirbu, Anca, Fica, Simona
Publicado 2015

Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycer...

por Jabbour, Serge A., Frías, Juan P., Guja, Cristian, Hardy, Elise, Ahmed, Azazuddin, Öhman, Peter
Publicado 2018

Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabete...

por Frías, Juan P., Hardy, Elise, Ahmed, Azazuddin, Öhman, Peter, Jabbour, Serge, Wang, Hui, Guja, Cristian
Publicado 2018

Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION‐7 randomized study

por Guja, Cristian, Frías, Juan P., Somogyi, Aniko, Jabbour, Serge, Wang, Hui, Hardy, Elise, Rosenstock, Julio
Publicado 2018

Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes

por Gastaldelli, Amalia, Repetto, Enrico, Guja, Cristian, Hardy, Elise, Han, Jenny, Jabbour, Serge A., Ferrannini, Ele
Publicado 2019

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

por Nemecz, Miruna, Stefan, Diana Simona, Comarița, Ioana Karla, Constantin, Alina, Tanko, Gabriela, Guja, Cristian, Georgescu, Adriana
Publicado 2023

Effectiveness and safety of insulin glargine Gla-300 in insulin-naïve type 2 diabetes subjects in a real-life setting—the GOAL_RO trial

por Stegaru, Daniela, Nicodim, Simona, Vladu, Delia, Guțu, Olimpia, Onaca, Adriana, Pîrvu, Florina, Moise, Mihaela, Guja, Cristian
Publicado 2021

Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled A...

por Haluzík, Martin, Seufert, Jochen, Guja, Cristian, Bonnemaire, Mireille, Bigot, Gregory, Tournay, Mathilde, Kis, János Tibor, Freemantle, Nick
Publicado 2023

Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease

por Guja, Cristian, Frías, Juan P., Suchower, Lisa, Hardy, Elise, Marr, Galina, Sjöström, C. David, Jabbour, Serge A.
Publicado 2020

Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease

por Guja, Cristian, Frías, Juan P., Suchower, Lisa, Hardy, Elise, Marr, Galina, Sjöström, C. David, Jabbour, Serge A.
Publicado 2020

Expert Opinion on the Therapeutic Use of the Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide: a Central/Eastern European Perspective

por Haluzík, Martin, Flekač, Milan, Lengyel, Csaba, Taybani, Zoltán, Guja, Cristian, Mihai, Bogdan-Mircea, Cerghizan, Anca, Martinka, Emil, Kovacs, Gabor, Kempler, Péter
Publicado 2020

Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results

por Guja, Cristian, Giorgino, Francesco, Blonde, Lawrence, Ali, Amar, Prázný, Martin, Meier, Juris J., Souhami, Elisabeth, Lubwama, Robert, Ji, Chen, Rosenstock, Julio
Publicado 2021

Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review

por Janež, Andrej, Guja, Cristian, Mitrakou, Asimina, Lalic, Nebojsa, Tankova, Tsvetalina, Czupryniak, Leszek, Tabák, Adam G., Prazny, Martin, Martinka, Emil, Smircic-Duvnjak, Lea
Publicado 2020

No Association between 25-Hydroxyvitamin D and Insulin Resistance or Thyroid Hormone Concentrations in a Romanian Observational Study

por Stoica, Roxana Adriana, Guja, Cristian, Pantea-Stoian, Anca, Staden, Raluca Ioana Ștefan-van, Popa-Tudor, Ioana, Ștefan, Simona Diana, Ancuceanu, Robert, Serafinceanu, Cristian, Ionescu Tîrgoviște, Constantin
Publicado 2020

Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: Pooled analysis of randomized active controlled clinical trials

por van der Aart ‐ van der Beek, Annemarie B., van Raalte, Daniel H., Guja, Cristian, Hoogenberg, Klaas, Suchower, Lisa J., Hardy, Elise, Sjöström, C. David, Heerspink, Hiddo J.L.
Publicado 2020

Interleukin-8, CXCL10, CXCL11 and their role in insulin resistance in adult females with subclinical hypothyroidism and prediabetes

por Stoica, Roxana Adriana, Drăgana, Nicoleta, Ancuceanu, Robert, Geicu, Ovidiu Ionuț, Guja, Cristian, Pantea-Stoian, Anca, Gheorghe, Damaris-Cristina, Stefan-van Staden, Raluca-Ioana, Serafinceanu, Cristian, Costache, Adrian, Ionescu-Tîrgoviște, Constantin
Publicado 2022